Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1970-7-17
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0001-6101
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
187
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
247-55
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:4911257-Clinical Trials as Topic,
pubmed-meshheading:4911257-Dihydroxyphenylalanine,
pubmed-meshheading:4911257-Dopamine,
pubmed-meshheading:4911257-Humans,
pubmed-meshheading:4911257-Parkinson Disease,
pubmed-meshheading:4911257-Phenylacetates,
pubmed-meshheading:4911257-Physical Therapy Modalities,
pubmed-meshheading:4911257-Placebos,
pubmed-meshheading:4911257-Tyrosine
|
| pubmed:year |
1970
|
| pubmed:articleTitle |
Oral L-dopa treatment of parkinsonism.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|